This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,547.42 firm fixed-price delivery order is for the supply of TABRECTA 200 MG TABLET (National Drug Code 4566554061) with no set-aside designation, indicating open competition. The contract has an ultimate completion date of December 18, 2024 and was awarded on November 26, 2024. AmerisourceBergen holds a...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $6,547.42 firm fixed-price delivery order covers the supply of TABRECTA 200 MG TABLET, a pharmaceutical product, to support government healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA to efficiently procure a comprehensive...
This Federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,428.06, is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The contract covers the delivery of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,428.06 firm-fixed-price delivery order is for TABRECTA 200 MG Tablets. The contract has an ultimate completion date of February 7, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award, with an identifier of SPE2DB24D3013|SPE2DB25FFJWN, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $14,428.06, is a delivery order contract with a firm fixed price pricing type. The contract is for the supply of TABRECTA 200 MG TABLET UU 56S, which are likely pharmaceutical products. The award has an ultimate completion date of March 24, 2025....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,094.84 firm fixed-price delivery order is for the supply of 4566306589 TABRECTA 200 MG TABLET UU 56S, with a completion date of November 25, 2024. This contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of TABRECTA 200 mg tablets to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $13,094.84. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical division. This IDC serves as the...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product TABRECTA 200 MG TABLET. The award has a potential value of $6,547.42 and a completion date of March 21, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors identified. The contract is not set aside for any specific...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of the pharmaceutical product TABRECTA 200 MG TABLET UU 56S, with a ceiling value of $13,094.84 and a period of performance through April 10, 2024. The contract is a firm fixed price delivery order, which is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $6,547.42 contract is for the delivery of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical product, with a completion date of September 27, 2024. The contract is a firm-fixed-price arrangement and does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and Indefinite...